Aska Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aska Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Fuso Pharmaceutical Industries Ltd
sales of 45.75 billion Japanese Yen [US$411.77 million]
of which 100%
was Pharmaceutical Business),
Nippon Chemiphar Co., Ltd.
(35.60 billion Japanese Yen [US$320.42 million]
of which 97%
was Pharmaceutical Business), and
Katakura Industries Co Ltd
(46.93 billion Japanese Yen [US$422.34 million]
Aska Pharmaceutical Company Limited reported sales of ¥43.22 billion (US$388.94 million)
March of 2016.
a very small
increase of 0.7%
versus 2015, when the company's sales were ¥42.91 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Aska Pharmaceutical Company Limited had sales
of ¥45.85 billion.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
7.0% in 2016, from
¥3.98 billion to ¥4.26 billion.